Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Inderbitzin

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Anesthesia and Analgesia|May 19, 2009
Automatic algorithm for monitoring systolic pressure variation and difference in pulse pressureGunther Pestel, Kimiko Fukui, Volker Hartwich, et al.
Clinical Colorectal Cancer|November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer PatientsJacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replicationMarianne Bonvin, François Achermann, Isabell Greeve, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 2004
Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liverYing Wang, Ursula Wimmer, Peter Lichtlen, et al.
Journal of Translational Medicine|April 1, 2014
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survivalViktor H Koelzer, Alessandro Lugli, Heather Dawson, et al.
Oncotarget|December 22, 2014
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancerJosé A Galván, Melina Helbling, Viktor H Koelzer, et al.
Virchows Archiv : an International Journal of Pathology|February 22, 2015
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver studyViktor H Koelzer, Inti Zlobec, Martin D Berger, et al.
Oncotarget|October 27, 2015
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancerChristian Schafroth, José A Galván, Irene Centeno, et al.
Oncotarget|July 13, 2014
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patientsMelina Helbling, Anne Lukesch, Aladin Haimovici, et al.
Clinical Epigenetics|September 28, 2018
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathwayJanina Graule, Kristin Uth, Elia Fischer, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Anesthesia and Analgesia|May 19, 2009
Automatic algorithm for monitoring systolic pressure variation and difference in pulse pressureGunther Pestel, Kimiko Fukui, Volker Hartwich, et al.
Clinical Colorectal Cancer|November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer PatientsJacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replicationMarianne Bonvin, François Achermann, Isabell Greeve, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 2004
Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liverYing Wang, Ursula Wimmer, Peter Lichtlen, et al.
Journal of Translational Medicine|April 1, 2014
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survivalViktor H Koelzer, Alessandro Lugli, Heather Dawson, et al.
Oncotarget|December 22, 2014
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancerJosé A Galván, Melina Helbling, Viktor H Koelzer, et al.
Virchows Archiv : an International Journal of Pathology|February 22, 2015
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver studyViktor H Koelzer, Inti Zlobec, Martin D Berger, et al.
Oncotarget|October 27, 2015
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancerChristian Schafroth, José A Galván, Irene Centeno, et al.
Oncotarget|July 13, 2014
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patientsMelina Helbling, Anne Lukesch, Aladin Haimovici, et al.
Clinical Epigenetics|September 28, 2018
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathwayJanina Graule, Kristin Uth, Elia Fischer, et al.
Pageof 6